Chain Drug Review - Heritage launches hydrochlorothiazide
November 19, 2007 -- [ILLUSTRATION OMITTED] EDISON, N.J. -- Heritage Pharmaceuticals Inc. has debuted hydrochlorothiazide (HCTZ) tablets USP. The product is indicated...
Photochemistry and Photobiology - Retinal Phototoxicity Induced by Hydrochlorothiazide After Exposure to a UV Tanning Device
September 1, 2008 -- ABSTRACT UV radiation is known to cause acute and chronic eye and skin damage. The present ease report describes the occurrence of...
International Journal of Applied Chemistry - Analysis of eprosartan-hydrochlorothiazide and irbesartan-hydrochlorothiazide binary mixtures by derivative spectrophotometry
January 1, 2007 -- Abstract Two simple and accurate spectrophotometric methods were presented for the determination of binary mixtures of each of Eprosartan and...
Business Wire - Teva Announces Tentative Approval of Losartan Potassium & Hydrochlorothiazide Tablets
June 14, 2006 -- JERUSALEM -- Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the U. S. Food and Drug Administration has granted tentative...
Business Wire - IVAX Receives Final Approval on Hydrochlorothiazide Capsules 12.5 mg
July 15, 2005 -- MIAMI -- IVAX Corporation (AMEX:IVX) (LSE:IVX.L) (WSE:IVX), received final approval from the U.S. Food and Drug Administration (FDA) for its...
Business Wire - King Pharmaceuticals Announces Plan to Report Positive Data from Phase III Clinical Trial Evaluating the Combination of ALTACE® with Hydrochlorothiazide
April 19, 2007 -- BRISTOL, Tenn. -- King Pharmaceuticals, Inc. (NYSE:KG) announced today that the Company has positive top-line results from the Phase III clinical...
Market Wire - FDA Approves Higher Dose Formulations of Diovan HCT(R) (Valsartan/Hydrochlorothiazide) for Treatment of High Blood Pressure
May 1, 2006 -- The U.S. Food and Drug Administration(FDA) approved two new, higher dose formulations of the high blood pressuremedication Diovan HCT
Business Wire - King Pharmaceuticals Reports Efficacy of ALTACE® 20mg And Efficacy of a Combination of ALTACE 20mg And Hydrochlorothiazide 25mg For 24-hour Blood Pressure...
May 20, 2007 -- BRISTOL, Tenn. -- The following was released on Saturday, May 19 and is being repeated. King Pharmaceuticals, Inc. (NYSE:KG) reported today that...
Business Wire - King Pharmaceuticals Announces Plan to Present Results from Phase III Clinical Trial Evaluating ALTACE® as Monotherapy and in Combination with...
May 8, 2007 -- BRISTOL, Tenn. -- King Pharmaceuticals, Inc. (NYSE:KG) announced today that the results from a Phase III clinical trial for its ALTACE([R])...
